Literature DB >> 8342322

Protection of mice from inhaled ricin by vaccination with ricin or by passive treatment with heterologous antibody.

J F Hewetson1, V R Rivera, D A Creasia, P V Lemley, M K Rippy, M A Poli.   

Abstract

Mice were vaccinated subcutaneously with 25 micrograms kg-1 of ricin in the presence of Freund's complete adjuvant or Ribi adjuvant, followed by a boost 14 days later with 50 micrograms kg-1 ricin in Freund's incomplete adjuvant or Ribi adjuvant, respectively. Three subsequent boosts at 28-day intervals with 25 micrograms kg-1 ricin yielded high anti-ricin antibody titres as determined by ELISA. Vaccinated animals were exposed to an aerosolized LD99 dose of ricin. With the exception of one death not attributable to ricin intoxication, all vaccinated mice survived the lethal aerosol exposure. In addition, a passive protection regimen was evaluated in mice pretreated with 100 micrograms purified goat anti-ricin IgG administered intravenously, and then challenged with ricin intravenously. All were resistant to 125 micrograms kg-1 of ricin, a dose greater than 25 times the intravenous lethal dose. Mice injected intravenously with 5 mg of the same IgG were protected from a lethal aerosol challenge. These results indicated that it is possible to protect animals from inhaled ricin by vaccination or passive administration of specific antibodies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8342322     DOI: 10.1016/0264-410x(93)90259-z

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosol.

Authors:  Joan E Smallshaw; James A Richardson; Ellen S Vitetta
Journal:  Vaccine       Date:  2007-08-30       Impact factor: 3.641

2.  Structural insights into the neutralization mechanism of monoclonal antibody 6C2 against ricin.

Authors:  Yuwei Zhu; Jianxin Dai; Tiancheng Zhang; Xu Li; Pengfei Fang; Huajing Wang; Yongliang Jiang; Xiaojie Yu; Tian Xia; Liwen Niu; Yajun Guo; Maikun Teng
Journal:  J Biol Chem       Date:  2013-07-12       Impact factor: 5.157

Review 3.  Immunity to ricin: fundamental insights into toxin-antibody interactions.

Authors:  Joanne M O'Hara; Anastasiya Yermakova; Nicholas J Mantis
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

4.  Immunoglobulin A antibodies against ricin A and B subunits protect epithelial cells from ricin intoxication.

Authors:  Nicholas J Mantis; Carolyn R McGuinness; Oluwakemi Sonuyi; Gary Edwards; Stephanie A Farrant
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

5.  Characterization of a novel high-affinity monoclonal immunoglobulin G antibody against the ricin B subunit.

Authors:  Carolyn R McGuinness; Nicholas J Mantis
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

6.  Truncated abrin A chain expressed in Escherichia coli: a promising vaccine candidate.

Authors:  Tao Zhang; Lin Kang; Shan Gao; Hao Yang; Wenwen Xin; Junhong Wang; Maowen Guo; Jinglin Wang
Journal:  Hum Vaccin Immunother       Date:  2014-11-17       Impact factor: 3.452

7.  Evidence for widespread epithelial damage and coincident production of monocyte chemotactic protein 1 in a murine model of intestinal ricin intoxication.

Authors:  J Marina Yoder; Rabia U Aslam; Nicholas J Mantis
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

8.  A monoclonal immunoglobulin G antibody directed against an immunodominant linear epitope on the ricin A chain confers systemic and mucosal immunity to ricin.

Authors:  Lori M Neal; Joanne O'Hara; Robert N Brey; Nicholas J Mantis
Journal:  Infect Immun       Date:  2009-10-26       Impact factor: 3.441

9.  A pilot clinical trial of a recombinant ricin vaccine in normal humans.

Authors:  Ellen S Vitetta; Joan E Smallshaw; Elaine Coleman; Hasan Jafri; Callie Foster; Robert Munford; John Schindler
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

10.  A lyophilized formulation of RiVax, a recombinant ricin subunit vaccine, retains immunogenicity.

Authors:  Joan E Smallshaw; Ellen S Vitetta
Journal:  Vaccine       Date:  2010-01-12       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.